(19)
(11) EP 3 937 959 A1

(12)

(43) Date of publication:
19.01.2022 Bulletin 2022/03

(21) Application number: 20715962.5

(22) Date of filing: 12.03.2020
(51) International Patent Classification (IPC): 
A61K 35/76(2015.01)
A61P 35/00(2006.01)
A61K 38/19(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/00; A61K 48/00; C12N 2710/10343; A61K 39/3955; C07K 2317/76; A61P 35/00; A61K 45/06; C12N 15/85; C07K 16/22; C07K 2317/24
 
C-Sets:
A61K 39/3955, A61K 2300/00;
(86) International application number:
PCT/IB2020/052260
(87) International publication number:
WO 2020/183424 (17.09.2020 Gazette 2020/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 13.03.2019 US 201962817735 P

(71) Applicant: Vascular Biogenics Ltd.
Modiin 7178106 (IL)

(72) Inventors:
  • RACHMILEWITZ MINEI, Tamar
    7178106 Modi'in (IL)
  • FAIN-SHMUELI, Shifra
    7178106 Modi'in (IL)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
P.O. Box 86 07 67
81634 München
81634 München (DE)

   


(54) METHODS OF ANTI-TUMOR THERAPY